In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014–2017 and 2018

•Clinical isolates were collected from central Europe and Israel, 2014–2017 and 2018.•Enterobacterales: susceptibility to ceftazidime-avibactam was ≥98.5%.•Pseudomonas aeruginosa: susceptibility to ceftazidime-avibactam was ≥86.3%. Between 2014 and 2017, 6,662 Enterobacterales and 1,953 P. aeruginos...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diagnostic microbiology and infectious disease 2021-09, Vol.101 (1), p.115420-115420, Article 115420
Hauptverfasser:	Kristóf, Katalin, Adámková, Václava, Adler, Amos, Gospodarek-Komkowska, Eugenia, Rafila, Alexandru, Billová, Sabina, Możejko-Pastewka, Barbara, Kiss, Ferenc
Format:	Artikel
Sprache:	eng
Schlagworte:	Ceftazidime-avibactam Enterobacterales Pseudomonas aeruginosa
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!